BioControl Medical
The imbalanced brain and heart connection<br/> in heart failure may contribute to poor heart function

The imbalanced brain and heart connection
in heart failure may contribute to poor heart function

The CardioFit therapy,<br/>a new approach to treat heart failure,<br/>activates a specific part of the body’s<br/>nervous system to reduce stress on the heart

The CardioFit therapy,
a new approach to treat heart failure,
activates a specific part of the body’s
nervous system to reduce stress on the heart

Now enrolling patients in a landmark<br/>clinical study at selected medical centers<br/>in the U.S. and Europe

Now enrolling patients in a landmark
clinical study at selected medical centers
in the U.S. and Europe

Clinical Trial Information

People that qualify for this clinical trial are 18 years of age or older and have been diagnosed with heart failure.

 

Health Professionals

Click here for more information.

 

Latest News & Events

Jan. 27, 2014
Israel Ministry of Health Approves Clinical Trials for BioControl Medical’s CardioFit® System in Heart Failure

Jul. 18, 2013
INOVATE-HF trial featured in the British Cardiomyopathy Association website

May. 26, 2013
U.S. Food and Drug Administration Approves Full Expansion of BioControl Medical’s INOVATE-HF Study of the CardioFit®

Nov. 7, 2012
Long Term Treatment Durability With CardioFit

Sep. 10, 2012
Video coverage of Allegheny General Hospital